Cinisello Balsamo, Italy

Eleonora Spuria

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chemi S.p.a.. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleonora Spuria: Innovator in Polypeptide Analysis

Introduction

Eleonora Spuria is a notable inventor based in Cinisello Balsamo, Italy. She has made significant contributions to the field of analytical chemistry, particularly in the analysis of complex polypeptide mixtures. Her work has implications for the pharmaceutical industry, especially in the development of therapeutic agents.

Latest Patents

Eleonora holds a patent titled "Analysis of the molecular weight distribution of complex polypeptide mixtures." This invention relates to simple size exclusion chromatography (SEC) analytical methods that are useful for assessing accurate molecular weight distributions (MWDs) of certain polypeptide mixtures known as glatiramoids. The SEC method she developed, based on one or more broad MWD standards, provides the absolute molecular weight distribution profile of complex polypeptide mixtures, such as glatiramer acetate (GA) polymer.

Career Highlights

Eleonora is currently employed at Chemi S.p.a., where she applies her expertise in analytical methods to advance the company's research and development efforts. Her innovative approach has positioned her as a key figure in her field.

Collaborations

Eleonora has collaborated with notable colleagues, including Andrea Stevenazzi and Andrea Distaso. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Chemi S.p.a.

Conclusion

Eleonora Spuria's contributions to the analysis of polypeptide mixtures exemplify the impact of innovative thinking in the scientific community. Her patent and work at Chemi S.p.a. highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…